EP3768304
SAMSETNINGAR OG AÐFERÐIR TIL AÐ AUKA EÐA BÆTA VEIRULEIÐSLU GENAMEÐFERÐARFERJA OG TIL AÐ FJARLÆGJA EÐA MINNKA ÓNÆMISGLÓBÚLÍN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.7.2019EP published:
12.10.2022EP application number:
19740384.3
EP translation filed:
9.1.2023Grant published:
15.7.2023EPO information:
European Patent Register
Max expiry date:
16.7.2039Expiry date:
16.7.2026Next due date:
31.7.2026
Title in English:
COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINSLanguage of the patent:
English
Timeline
Today
17.7.2019EP application
12.10.2022EP Publication
9.1.2023Translation submitted
15.7.2023Registration published
16.7.2026Expires
Owner
Name:
INSERM (Institut National de la Santé et de la Recherche Médicale)Address:
101, rue de Tolbiac, 75013 Paris Cédex 13, FR
Name:
GenethonAddress:
1 bis rue de l'Internationale, 91000 Evry, FR
Name:
Sorbonne UniversitéAddress:
21, rue de l'Ecole de Médecine, 75006 Paris, FR
Name:
Université Paris CitéAddress:
85 boulevard Saint-Germain, 75006 Paris, FR
Name:
Spark Therapeutics, Inc.Address:
3737 Market Street Suite 1300, Philadelphia, Pennsylvania 19104, US
Inventor
Name:
LACROIX-DESMAZES, SébastienAddress:
75006 Paris, FR
Name:
MINGOZZI, FedericoAddress:
Philadelphia, PA 19118, US
Name:
DIMITROV, JordanAddress:
75006 PARIS, FR
Name:
LEBORGNE, ChristianAddress:
91000 Evry, FR
Name:
ARMOUR, SeanAddress:
Holland, PA 18966, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
18305971Date:
17.7.2018Country:
EP
Number:
201862768731 PDate:
16.11.2018Country:
US
Classification
Categories:
A61K 38/48, A61K 39/12, C12N 9/64
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 22.6.2023
Expires: 16.7.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 19.6.2024
Expires: 16.7.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 8.7.2025
Expires: 16.7.2026
Payer: Árnason Faktor ehf.